LABIANA HEALTH S.A.EO-10 (8RK) — Cash Flow Reinvestment Rate
LABIANA HEALTH S.A.EO-10 (8RK) has a Cash Flow Reinvestment Rate of 0.55x as of December 2024, reinvesting €3.95 Million (capex €3.05 Million plus investments €-902.84K) from operating cash flow of €7.19 Million. Check LABIANA HEALTH S.A.EO-10 (8RK) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
LABIANA HEALTH S.A.EO-10 Cash Flow Reinvestment Rate (2021–2024)
Historical reinvestment intensity for LABIANA HEALTH S.A.EO-10 across 3 annual periods. Explore cash flow to debt ratio of LABIANA HEALTH S.A.EO-10 to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for LABIANA HEALTH S.A.EO-10 (2021–2024)
Year-by-year capital reinvestment analysis for LABIANA HEALTH S.A.EO-10. For live market cap and broader valuation context, see LABIANA HEALTH S.A.EO-10 market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.55x | €3.95 Million | €7.19 Million | €3.05 Million | ▼ -67.7% |
| 2022 | 1.70x | €7.96 Million | €4.68 Million | €5.45 Million | ▼ -21.7% |
| 2021 | 2.17x | €8.49 Million | €3.91 Million | €4.77 Million | — |